Recruiting Atrial Fibrillation Studies in Manhattan
About Atrial Fibrillation Clinical Trials in Manhattan
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in Manhattan, NY. These studies are seeking a combined 750 participants. Research is being sponsored by Milestone Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Manhattan — FAQ
Are there atrial fibrillation clinical trials in Manhattan?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in Manhattan, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Manhattan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Manhattan research site will contact you about next steps.
Are clinical trials in Manhattan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Manhattan studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in Manhattan are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated October 16, 2026 from ClinicalTrials.gov